FOXR2-ACTIVATED

Clinical trials for FOXR2-ACTIVATED explained in plain language.

Never miss a new study

Get alerted when new FOXR2-ACTIVATED trials appear

Sign up with your email to follow new studies for FOXR2-ACTIVATED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for kids with incurable brain cancer: First-in-Human trial launches

Disease control Recruiting now

This early-stage trial is testing a new type of personalized cell therapy for children and young adults whose aggressive brain tumors have come back or not responded to standard treatments. Doctors take a patient's own immune cells, genetically modify them to target a protein (GP…

Matched conditions: FOXR2-ACTIVATED

Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

FOXR2-ACTIVATED

Get alerted when new FOXR2-ACTIVATED trials appear

New hope for kids with incurable brain cancer: First-in-Human trial launches